In this video we will dive into a study that explored the incidence of COVID-19 in countries that have prophylaxis programs using Ivermectin. In many countries, Ivermectin is used as a prophylaxis agent for parasitic infections. This studied focused on these countries comparing them to other countries that have parasitic prophylactic programs that don’t use Ivermectin, as well as countries without prophylaxis programs at all. They did this on a global scale and then focused in on countries within the continent of Africa. They found a statistically significant decrease in COVID-19 incidence in countries that utilized Ivermectin prophylaxis programs. What does this mean though and what are the limitations? Check out the video for the details!

Link to study: https://www.sciencedirect.com/science…

In this video we will dive into a study published in the International Journal Of Infectious Disease that treated hospitalized patients with COVID-19 with either Ivermectin, Ivermectin and Doxycycline, or Placebo (with standard care). They looked specifically at the time to viral clearance, oxygen requirements, and mortality. The setup of the trial was interesting as they excluded anyone with comorbid conditions, which led to a fairly young and healthy population. The mortality in the study overall was zero and no one required oxygen. Nonetheless, they did find some significant results. Check out the video for all the details! Link to study: https://www.ijidonline.com/article/S1…